Document is current
Any future updates will be listed below
-
Authors
Swanson, Kyle https://orcid.org/0000-0002-7385-7844
Liu, Gary https://orcid.org/0009-0008-3386-6974
Catacutan, Denise B https://orcid.org/0009-0003-0146-5344
McLellan, Stewart
Arnold, Autumn
Tu, Megan M
Brown, Eric D https://orcid.org/0000-0002-7624-8112
Zou, James https://orcid.org/0000-0001-8880-4764
Stokes, Jonathan M https://orcid.org/0009-0001-8378-2380
-
Funding
Funding for this research was provided by:
Weston Family Foundation
David Braley Centre for Antibiotic Discovery
Canadian Institutes of Health Research (PJT 186281)
Natural Sciences and Engineering Research Council of Canada
M. and M. Heersink
Chan Zuckerberg Initiative
Knight-Hennessy Scholarship
SU | Stanford Bio-X
Canada Research Chairs
- License Information
-
More Information
Article History
Received: 21 February 2026
Revised: 9 March 2026
Accepted: 18 March 2026
First Online: 23 April 2026
Disclosure and competing interests statement
: KS is currently an employee of Flex Therapeutics and was previously a part-time employee of Greenstone Biosciences and a consultant at Merck & Co., Inc during this work. GL and DBC are consultants for Stoked Bio. JMS is a founder of Stoked Bio.
